About: Gonadotropin-releasing hormone agonists administration in polycystic ovary syndrome. Effects on bone mass

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Gonadotropin-releasing hormone agonists administration in polycystic ovary syndrome. Effects on bone mass Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 1997

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 1997 (uk) im September 1997 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en setiembre de 1997 (ast) scientific article published on 01 September 1997 (en)
publication date	wds:Q73864602-9D1663FE-C440-434E-90AC-72808723B470
publication date	1997-09-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q73864602-28DC8E06-CAFE-490A-899D-99F6FAD3A09D
exact match	https://scigraph.springernature.com/pub.10.1007/bf03348007
cites work	wds:Q73864602-38B3DAF9-B4CB-475A-8383-4C5EEC77954E wds:Q73864602-3E1E8025-B0C9-4399-8863-38436A9C65AD wds:Q73864602-4FF22ED8-A44A-4B08-A1C9-CD8DFF40D81F wds:Q73864602-53E6CFA8-4AE0-4B32-97D1-5562690F275E wds:Q73864602-5E788D1F-DD65-4929-A7A7-A84EF0C9919E wds:Q73864602-71460B40-DACD-488B-B385-ED8591EA174F wds:Q73864602-84E23CB7-3FED-46E4-88AD-9EF110D580B7 wds:Q73864602-875835A0-F9DE-4D50-86E4-B0258E124F3F wds:Q73864602-8E2CE40C-69B0-4065-AABC-4A31FECF4DEC wds:Q73864602-8E76921E-5485-4FC1-BF70-3E634A89E47E wds:Q73864602-8E839BA4-0D5C-4B7D-BB27-97A1F26BB69A wds:Q73864602-9C255F97-9092-4B9F-BCE1-64C97D6DC10F wds:Q73864602-ACD7E1F2-5977-4045-9E96-F0D4060A3E9F wds:Q73864602-B41C8DFD-C9EE-4480-A8E8-B79140D85448 wds:Q73864602-C249EF48-6844-4BAC-A74A-05C24B0CB6A3 wds:Q73864602-E2831959-103F-4C76-A812-E3B6B38609AE wds:Q73864602-E6B22DB8-8E69-4430-B4B2-FFB83B8DF4B8 wds:Q73864602-E85286D1-F2EB-4569-83CE-2C46D345BDC8 wds:Q73864602-EB5EBA41-BB75-47AF-B8B8-854A97E99F81
cites work	Polycystic ovaries as a relative protective factor for bone mineral loss in young women with amenorrhea The effect of obesity on postmenopausal bone loss and the risk of osteoporosis Reversible trabecular bone density loss following induced hypo-oestrogenism with the GnRH analogue buserelin in premenopausal women Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study. Evidence for alteration of the vitamin D-endocrine system in obese subjects Effect of gonadotropin-releasing hormone agonist on the bone mineral density of patients with endometriosis A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri Treatment with a gonadotropin-releasing hormone agonist in acne or idiopathic hirsutism Physiological estrogen replacement may enhance the effectiveness of the gonadotropin-releasing hormone agonist in the treatment of hirsutism The relationship between circulating androgens, obesity, and hyperinsulinemia on serum insulin-like growth factor binding protein-1 in the polycystic ovarian syndrome GnRH agonists and antagonists. Current clinical status Impact of medical treatment of endometriosis on bone mass Comparison of a gonadotropin-releasing hormone agonist and a low dose oral contraceptive given alone or together in the treatment of hirsutism Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study. Effects of alendronate on bone loss in pre- and postmenopausal hyperthyroid women treated with methimazole The prevention of bone loss in young women treated with GnRH analogues with "add-back" estrogen therapy Reversible bone loss in women treated with GnRH-agonists for endometriosis and uterine leiomyoma The correlation of serum estrogens and androgens with bone density in the late postmenopause Gonadotropin-releasing hormone agonist (GnRH-A) in hirsutism
author name string	wds:Q73864602-49FD27EC-A809-4EBF-86E7-388349D7B994 wds:Q73864602-5106E037-9745-476C-B06D-B0DD94E317B1 wds:Q73864602-55A1B23A-5F94-4039-B996-C7F1309DDF8F wds:Q73864602-98AEEBB5-D8D8-4801-A9F7-2776FD704BAF wds:Q73864602-C7458127-6103-467A-A861-F2C00FC0863F wds:Q73864602-D28A4D8A-37BF-4E32-ADAD-3031DCDF44FB
author name string	G Vitale G Lupoli V Nuzzo D Russo C Nappi C Di Carlo
rdfs:label	Gonadotropin-releasing hormone agonists administration in polycystic ovary syndrome. Effects on bone mass (en) Gonadotropin-releasing hormone agonists administration in polycystic ovary syndrome. Effects on bone mass (nl)
skos:prefLabel	Gonadotropin-releasing hormone agonists administration in polycystic ovary syndrome. Effects on bone mass (en) Gonadotropin-releasing hormone agonists administration in polycystic ovary syndrome. Effects on bone mass (nl)
name	Gonadotropin-releasing hormone agonists administration in polycystic ovary syndrome. Effects on bone mass (en) Gonadotropin-releasing hormone agonists administration in polycystic ovary syndrome. Effects on bone mass (nl)
author	wds:Q73864602-DF0C21D5-FC84-4A65-9474-FAED1249CDFE
author	Stefano Palomba
title	wds:Q73864602-CC13760D-E07C-4CC4-A7B7-CE89A8704152
title	Gonadotropin-releasing hormone agonists administration in polycystic ovary syndrome. Effects on bone mass (en)
page(s)	wds:Q73864602-B8A6FF9E-4FC9-436C-99D6-DD6BBCA46F44
page(s)	493-496
instance of	wds:Q73864602-E97D7F1A-A075-4946-AC69-C6AC23C48BBC
instance of	scholarly article
main subject	wds:Q73864602-09B0F198-53AF-46CF-986A-D4E89288B3CC wds:Q73864602-6532AF0A-F26B-4BAD-BA73-A18617A97F9C
main subject	polycystic ovary syndrome polycystic ovary
PubMed ID	wds:Q73864602-9BFB6F5B-21A0-4957-94F0-7DCD77773BCE
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9364254
PubMed ID	9364254
published in	wds:Q73864602-FAEC1BE1-DBA1-4E7B-88E3-D562678AE7B1
published in	Journal of Endocrinological Investigation
issue	wds:Q73864602-3CB5346D-934E-44EE-ACCE-77463A7E031A
volume	wds:Q73864602-41481832-E774-492D-A91E-730ED6398878
issue	8
volume	20
DOI	wds:Q73864602-90402D3B-1BBF-4A19-98DF-C8FD3BBC223B
DOI	http://dx.doi.org/10.1007/BF03348007
DOI	10.1007/BF03348007
Dimensions Publication ID	wds:Q73864602-46324468-1F1E-4492-8334-ACBBAF6106AD
Dimensions Publication ID	1012919348
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73864602
is cites work of	Menstrual disorders in adolescents. Excess androgens and the polycystic ovary syndrome A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata. Circulating osteoprotegerin in women during GnRH-agonist treatment and their relationships with mineral components and biomarkers of bone turnover Polycystic ovary syndrome, androgen excess, and the impact on bone.
is cites work of	wds:Q47860836-D1AC06D7-F202-498E-B492-DBF9D210E0A3 wds:Q33671808-0AF21D49-099A-4AC2-A5FD-0B66CE6CBFBC wds:Q44658955-FA3BE30C-B89E-4196-A282-45525A608CED

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software